Journal article icon

Journal article

Quick reference guide to apixaban

Abstract:

Direct oral anticoagulants (DOACs) are being increasingly used in the clinical setting for patients at risk of venous thromboembolism (VTE) and/or stroke. These medications offer valued benefits for long-term use, including a fast onset of anticoagulation, fixed anticoagulation profile (and consequent prescription of specified doses) and no requirement for routine monitoring. Apixaban is a selective factor Xa inhibitor, approved for use in the prevention of stroke in patients with nonvalvular...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.2147/vhrm.s121944

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Surgical Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Surgical Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Oxford college:
St Catherine's College
Role:
Author
Publisher:
Dove Press Publisher's website
Journal:
Vascular Health and Risk Management Journal website
Volume:
13
Pages:
263-267
Publication date:
2017-07-10
Acceptance date:
2017-01-10
DOI:
EISSN:
1178-2048
ISSN:
1176-6344
Pmid:
28744136
Language:
English
Keywords:
Pubs id:
pubs:709576
UUID:
uuid:37b60fd8-c471-420f-8d68-bbc222b59247
Local pid:
pubs:709576
Source identifiers:
709576
Deposit date:
2017-12-04

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP